+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Primary Cells Market by Origin (Animal Primary Cells, Human Primary Cells), Cell Type (Dermatocytes, Gastrointestinal Cells, Heart Cells), End-User - Forecast 2024-2030- Product Image
Global Primary Cells Market by Origin (Animal Primary Cells, Human Primary Cells), Cell Type (Dermatocytes, Gastrointestinal Cells, Heart Cells), End-User - Forecast 2024-2030- Product Image
Sale

Global Primary Cells Market by Origin (Animal Primary Cells, Human Primary Cells), Cell Type (Dermatocytes, Gastrointestinal Cells, Heart Cells), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5201072
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Primary Cells Market size was estimated at USD 1.43 billion in 2023, USD 1.60 billion in 2024, and is expected to grow at a CAGR of 12.10% to reach USD 3.18 billion by 2030.

Primary cells are the fundamental building blocks of tissues and organs and exhibit natural biological behavior similar to their origin, making them an essential tool in various scientific applications. Increased investment in regenerative medicine and cell-based research drives primary cells' need to develop innovative therapeutic solutions. Technological advancements such as CRISPR gene-editing techniques have expanded primary cell usage by offering more precise manipulation tools for targeted therapies.

However, primary cells may exhibit donor-to-donor variability due to genetic and environmental factors influencing their biology, potentially limiting their reproducibility in research settings. Nevertheless, the increasing number of life sciences collaborations between academic institutions, research laboratories, and biopharmaceutical manufacturers is expected to contribute to exploring primary cell-based therapies.

Regional Insights

Americas region showcases significant growth primarily due to the presence of well-established biotechnology and pharmaceutical industries in countries such as the United States and Canada. The rapid adoption of advanced technologies in cell culture methodologies and increasing investments in research & development activities contribute to this region's strong performance. Furthermore, several government initiatives aimed at promoting novel therapies using primary cells have spurred growth in this sector. In the APAC region, countries such as China and India are experiencing considerable expansion of their biopharmaceutical sectors.

This is attributed to factors such as a growing elderly population with a higher prevalence of chronic diseases requiring innovative treatment options, increased healthcare expenditure, and a greater focus on research & development activities. As a result, there has been a surge in demand for primary cells within this region. Additionally, Japan boasts a strong presence in regenerative medicine research, which has led to increased utilization of primary cells for therapeutic purposes. Europe is experiencing significant growth with its robust R&D framework supported by substantial investments from both governmental organizations and private entities. Countries such as Germany, France, Italy, UK, Spain, and the Netherlands have all contributed significantly through their respective biotechnology pharmaceutical industries, shaping up an overall progressive scenario within the EMEA region.

Market Trends by Segment

  • Origin: Increasing preference for human primary cells for accurate representations of human cellular responses
  • Cell Type: Rising adoption of dermatocytes in drug development and toxicity testing
  • End-User: Proliferating use of primary cells in life science companies to ensure accurate results during experimentation

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

CN Bio and LifeNet Health LifeSciences Partner to Supply Validated Primary Human Cells for Microphysiological Systems

CN Bio and LifeNet Health have joined forces to supply primary human cells for use in CN Bio's PhysioMimix Organ-on-a-Chip (OOC) microphysiological systems. This collaboration aims to provide customers with access to well-characterized and MPS-validated cells that have undergone prequalification by CN Bio. These cells are designed to maintain their function and phenotype for a minimum of two weeks and come with comprehensive donor medical and genetic information.

AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery

AnaBios Corporation has acquired Cell Systems, specializing in human primary cells and cell culture media, to expand in the field of drug discovery and cell biology research. With access to an extensive range of biologically relevant tools, scientists can now expedite their drug discovery efforts and deepen their understanding of cell biology. This acquisition opens up new opportunities for researchers worldwide.

Human Cell Design Launches Endoc-BH5, an Advanced Human Beta Cell Model enabling New Discoveries in Type 1 and 2 Diabetes Research

Human Cell Design has launched Endoc-BH5, the fifth version of its model of ready-to-use, >99% pure population of functional human pancreatic beta cells. This innovative product addresses the challenges associated with native beta cells, such as limited availability, batch-to-batch variability, flexibility, and genome editing compatibility. Endoc-BH5 bridges the gap between previous versions and native human pancreatic beta cells.

Key Company Profiles

The report delves into recent significant developments in the Primary Cells Market, highlighting leading vendors and their innovative profiles. These include Biopredic International, Corning Incorporated, Danaher Corporation, FUJIFILM Irvine Scientific, Inc., Lonza AG, PromoCell GmbH, Reachbio LLC, Sciencell Research Laboratories, Inc., Sekisui Xenotech, LLC, Stem Cell Technologies, Inc., StemExpress, LLC, The Bio Convergence Company, The Merck Group, Thermo Fisher Scientific, Inc., and Zenbio, Inc.

This research report offers invaluable insights into various crucial aspects of the Primary Cells Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing acceptance in drug screening and cell based assays
5.1.1.2. Advantages of primary human cells over other existing methods
5.1.1.3. Growing focus on monoclonal antibodies and personalized medicine
5.1.2. Restraints
5.1.2.1. Common cell culture problems such as contamination
5.1.3. Opportunities
5.1.3.1. Expanding biotechnology and biopharmaceutical industries
5.1.3.2. Advancements in biomedical research using primary cells
5.1.4. Challenges
5.1.4.1. Ethical issues in cell biology research field
5.2. Market Segmentation Analysis
5.2.1. Origin: Increasing preference for human primary cells for accurate representations of human cellular responses
5.2.2. Cell Type: Rising adoption of dermatocytes in drug development and toxicity testing
5.2.3. End-User: Proliferating use of primary cells in life science companies to ensure accurate results during experimentation
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Primary Cells Market, by Origin
6.1. Introduction
6.2. Animal Primary Cells
6.3. Human Primary Cells
7. Primary Cells Market, by Cell Type
7.1. Introduction
7.2. Dermatocytes
7.3. Gastrointestinal Cells
7.4. Heart Cells
7.5. Hematopoietic Cells
7.6. Hepatocytes
7.7. Lung Cells
7.8. Musculoskeletal Cells
7.9. Renal Cells
8. Primary Cells Market, by End-User
8.1. Introduction
8.2. Life Science Companies
8.3. Research Institutes
9. Americas Primary Cells Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Primary Cells Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Primary Cells Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. CN Bio and LifeNet Health LifeSciences Partner to Supply Validated Primary Human Cells for Microphysiological Systems
12.3.2. AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery
12.3.3. Human Cell Design Launches Endoc-BH5, an Advanced Human Beta Cell Model enabling New Discoveries in Type 1 and 2 Diabetes Research
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. PRIMARY CELLS MARKET RESEARCH PROCESS
FIGURE 2. PRIMARY CELLS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PRIMARY CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PRIMARY CELLS MARKET DYNAMICS
FIGURE 7. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PRIMARY CELLS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. PRIMARY CELLS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PRIMARY CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PRIMARY CELLS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PRIMARY CELLS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PRIMARY CELLS MARKET SIZE, BY ANIMAL PRIMARY CELLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PRIMARY CELLS MARKET SIZE, BY ANIMAL PRIMARY CELLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PRIMARY CELLS MARKET SIZE, BY HUMAN PRIMARY CELLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PRIMARY CELLS MARKET SIZE, BY HUMAN PRIMARY CELLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PRIMARY CELLS MARKET SIZE, BY DERMATOCYTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PRIMARY CELLS MARKET SIZE, BY DERMATOCYTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PRIMARY CELLS MARKET SIZE, BY GASTROINTESTINAL CELLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PRIMARY CELLS MARKET SIZE, BY GASTROINTESTINAL CELLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEART CELLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEART CELLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEMATOPOIETIC CELLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEMATOPOIETIC CELLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PRIMARY CELLS MARKET SIZE, BY CRYOPRESERVED HEPATOCYTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PRIMARY CELLS MARKET SIZE, BY CRYOPRESERVED HEPATOCYTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PRIMARY CELLS MARKET SIZE, BY FRESH HEPATOCYTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PRIMARY CELLS MARKET SIZE, BY FRESH HEPATOCYTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PRIMARY CELLS MARKET SIZE, BY LUNG CELLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PRIMARY CELLS MARKET SIZE, BY LUNG CELLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PRIMARY CELLS MARKET SIZE, BY MUSCULOSKELETAL CELLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PRIMARY CELLS MARKET SIZE, BY MUSCULOSKELETAL CELLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL PRIMARY CELLS MARKET SIZE, BY RENAL CELLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL PRIMARY CELLS MARKET SIZE, BY RENAL CELLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL PRIMARY CELLS MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL PRIMARY CELLS MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL PRIMARY CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL PRIMARY CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. CANADA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 70. CANADA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 71. CANADA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 72. CANADA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 73. CANADA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 74. CANADA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 75. CANADA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. CANADA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. MEXICO PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 78. MEXICO PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 79. MEXICO PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 80. MEXICO PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 81. MEXICO PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 82. MEXICO PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 83. MEXICO PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 84. MEXICO PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. CHINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 114. CHINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 115. CHINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 116. CHINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 117. CHINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 118. CHINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 119. CHINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 120. CHINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 121. INDIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 122. INDIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 123. INDIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 124. INDIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 125. INDIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 126. INDIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 127. INDIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. INDIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. JAPAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 138. JAPAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 139. JAPAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 140. JAPAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 141. JAPAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 142. JAPAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 143. JAPAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 144. JAPAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. THAILAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 186. THAILAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 187. THAILAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 188. THAILAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 189. THAILAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 190. THAILAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 191. THAILAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. THAILAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 211. DENMARK PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 212. DENMARK PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 213. DENMARK PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 214. DENMARK PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 215. DENMARK PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 216. DENMARK PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 217. DENMARK PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 218. DENMARK PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 219. EGYPT PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 220. EGYPT PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 221. EGYPT PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 222. EGYPT PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 223. EGYPT PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 224. EGYPT PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 225. EGYPT PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. EGYPT PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. FINLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 228. FINLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 229. FINLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 230. FINLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 231. FINLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 232. FINLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 233. FINLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. FINLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. FRANCE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 236. FRANCE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 237. FRANCE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 238. FRANCE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 239. FRANCE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 240. FRANCE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 241. FRANCE PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. FRANCE PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. GERMANY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 244. GERMANY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 245. GERMANY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 246. GERMANY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 247. GERMANY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 248. GERMANY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 249. GERMANY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. GERMANY PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. ITALY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 260. ITALY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 261. ITALY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 262. ITALY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 263. ITALY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 264. ITALY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 265. ITALY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 266. ITALY PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. NORWAY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 284. NORWAY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 285. NORWAY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 286. NORWAY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 287. NORWAY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 288. NORWAY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 289. NORWAY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 290. NORWAY PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 291. POLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 292. POLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 293. POLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 294. POLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 295. POLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 296. POLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 297. POLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 298. POLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 299. QATAR PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 300. QATAR PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 301. QATAR PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 302. QATAR PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 303. QATAR PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 304. QATAR PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 305. QATAR PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 306. QATAR PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 313. RUSSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 314. RUSSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 322. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 328. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 330. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 331. SPAIN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 332. SPAIN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 333. SPAIN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 334. SPAIN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 335. SPAIN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 336. SPAIN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 337. SPAIN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 338. SPAIN PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 340. SWEDEN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 341. SWEDEN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 342. SWEDEN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 343. SWEDEN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 344. SWEDEN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 345. SWEDEN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 346. SWEDEN PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 347. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 348. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 349. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 350. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 351. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 352. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 353. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 354. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 355. TURKEY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 356. TURKEY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 357. TURKEY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 358. TURKEY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 359. TURKEY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 360. TURKEY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 361. TURKEY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 362. TURKEY PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 365. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 366. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 367. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 368. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 369. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 370. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 371. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 372. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 373. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
TABLE 374. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
TABLE 375. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
TABLE 376. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
TABLE 377. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 378. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 379. PRIMARY CELLS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 380. PRIMARY CELLS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Biopredic International
  • Corning Incorporated
  • Danaher Corporation
  • FUJIFILM Irvine Scientific, Inc.
  • Lonza AG
  • PromoCell GmbH
  • Reachbio LLC
  • Sciencell Research Laboratories, Inc.
  • Sekisui Xenotech, LLC
  • Stem Cell Technologies, Inc.
  • StemExpress, LLC
  • The Bio Convergence Company
  • The Merck Group
  • Thermo Fisher Scientific, Inc.
  • Zenbio, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.18 Billion
Compound Annual Growth Rate12.1%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Global Primary Cells Market by Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Pharma Biotech, CROs, Academia), Region - Forecast to 2028 - Product Image

Global Primary Cells Market by Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Pharma Biotech, CROs, Academia), Region - Forecast to 2028

  • Report
  • 217 Pages
  • Global
From
Induced Pluripotent Stem Cells Market Size, Share & Trends Analysis Report By Derived Cell Type (Hepatocytes, Fibroblasts), By Application (Drug Development, Toxicology Research), End-user, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Induced Pluripotent Stem Cells Market Size, Share & Trends Analysis Report By Derived Cell Type (Hepatocytes, Fibroblasts), By Application (Drug Development, Toxicology Research), End-user, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024 - Product Image

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2023 - Product Image

Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2023

  • Report
  • 326 Pages
  • Global
From
Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.